Format

Send to

Choose Destination
Sb Lek. 2000;101(4):381-6.

[Hypocretin (orexin) deficiency in narcolepsy-cataplexy].

[Article in Czech]

Author information

1
Neurologická klinika 1. lékarské fakulty, Univerzity Karlovy a Vseobecné fakultní nemocnice, Katerinská 30, 120 00 Praha 2, Czech Republic. snevsi@lf1.cuni.cz

Abstract

A mutation in the HCRT locus was proved in 18-yrs old male suffering from narcolepsy-cataplexy. He has demonstrated cataplectic attacks (brief spells of head dropping provoked by laughter) as well as imperative sleep in spells of several minutes up to one hour since the age of six months. He has suffered from severe bulimia since five years; later hypnagogic hallucinations, sleep paralysis and unquiet nocturnal sleep accompanied by periodic limb movements appeared. Symptoms are partially controlled with methylphenidate and either imipramine, clomipramine or fluoxetine. Periodic leg movements poorly responded to L-DOPA and clonazepam treatment. He is HLA-DQB1*0602 negative. Repeated MSLT (over 16 years followed-up period) showed extremely short latency with predominant SOREMPs and also nocturnal PSG recordings revealed fragmented sleep with SOREMPs. This case report demonstrates that hypocretin (orexin) mutations in human can produce the full narcolepsy phenotype and validates data recently reported in dog and mouse models suggesting a role for hypocretin (orexin) in the pathophysiology of narcolepsy and the regulation of REM sleep.

PMID:
11702580
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center